Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PLAPROVA

Financiado

Cerrado

Plant Production of Vaccines

Advances in the technologies for expressing proteins and extracting them from plants have allowed several plant-made products to be assessed for safety and efficacy. The results have been favourable and have culminated in the demo... ver más

31/12/2011

JOHN INNES CENTRE

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto

JOHN INNES CENTRE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 10 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2011-12-31 No tenemos la información de la convocatoria

0% 77% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

10 Participantes

JOHN INNES CENTRE

0.00€ | Lider

N.D. | Participante

CNR

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

NUEVA VACUNA CLOSTRIDIAL POLIVALENTE UTILIZA... NUEVA VACUNA CLOSTRIDIAL POLIVALENTE UTILIZANDO ANTIGENOS O... 813K€ Cerrado

BIO2012-31251 DESARROLLO Y OPTIMIZACION DE BIOPROCESOS PARA LA PRODUCCION... 176K€ Cerrado

OvaVAx 100 Bacteria free eggs for use in production of human and a... 3M€ Cerrado

Investigación y desarrollo de nuevas enzimas... Investigación y desarrollo de nuevas enzimas para la síntesi... 332K€ Cerrado

BIO2011-23330 DESARROLLO DE UNA PLATAFORMA DE BIOPROCESO PARA LA PRODUCCIO... 48K€ Cerrado

PTQ2018-009904 Desarrollo de una vacuna recombinante experimental frente al... 115K€ Cerrado

Líder del proyecto

JOHN INNES CENTRE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 3M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Advances in the technologies for expressing proteins and extracting them from plants have allowed several plant-made products to be assessed for safety and efficacy. The results have been favourable and have culminated in the demonstration that plant-produced vaccine can protect target animals against challenge. However, most of these successes have concerned the production of antigens which had previously been produced using established methods such as mammalian cell culture. For plants to fulfil their potential as a means of producing vaccines, it is now imperative that methods are developed for the rapid production and characterisation of a large number of vaccine candidates. This project will exploit recent developments in transient expression technologies to screen a range of vaccine candidates in plants. These methods can produce milligram quantities of candidate proteins in a matter of days using only small amounts (tens of grams) of plant tissue. The project will concentrate on screening vaccine candidate proteins which are capable of forming virus-like particles (VLPs), as such particulate structures are known to be potent stimulators of the immune system. Furthermore, they can be used as carriers of additional immunogenic sequences for the developments of novel vaccines. The project will focus on diseases which are particularly relevant to both the EU and Russia, including Avian Influenza virus (AIV), Blue Tongue Virus (BTV) Porcine Respiratory and Reproductive Syndrome Virus (PRRSV). The ability to screen many candidate VLPs will result in the development of novel vaccines against these and other important pathogens. At the same time as the screening is carried out, methods will be developed to allow the rapid translation of the information gained through the transient studies into larger scale production systems for the most promising candidates. This will enable low cost vaccines to be developed for use for livestock and, ultimately, humans.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores